4//SEC Filing
ROGERS MICHAEL W 4
Accession 0001562180-19-003630
CIK 0001314102other
Filed
Jun 23, 8:00 PM ET
Accepted
Jun 24, 4:31 PM ET
Size
8.0 KB
Accession
0001562180-19-003630
Insider Transaction Report
Form 4
ROGERS MICHAEL W
Director
Transactions
- Exercise/Conversion
Deferred Stock Units
2019-06-21−6,667→ 0 total→ Common Stock (6,667 underlying) - Exercise/Conversion
Common Stock
2019-06-21+6,667→ 119,167 total
Footnotes (2)
- [F1]Represents vesting of deferred stock units ("DSUs") previously awarded to the reporting person, with each deferred stock unit representing the right to receive one share of the common stock of EyePoint Pharmaceuticals, Inc. (the "Company").
- [F2]On June 21, 2018, the reporting person was granted 6,667 DSUs. The DSUs vested in full on June 21, 2019 and will be settled solely in shares of the Company's common stock upon the earliest to occur of: (i) the reporting person's termination of service on the Company's Board of Directors and (ii) the occurrence of a "change in control" (as defined in the applicable award agreement) that constitutes a "change in the ownership or effective control of" the Company or "a change in the ownership of a substantial portion of the assets of" the Company, in each case, as determined under Section 409A of the Internal Revenue Code of 1986, as amended, and the regulations issued thereunder.
Documents
Issuer
EyePoint Pharmaceuticals, Inc.
CIK 0001314102
Entity typeother
Related Parties
1- filerCIK 0001244159
Filing Metadata
- Form type
- 4
- Filed
- Jun 23, 8:00 PM ET
- Accepted
- Jun 24, 4:31 PM ET
- Size
- 8.0 KB